Anti-Smoking Drug, Chantix Linked to Suicidal Behavior in Patients
May 3rd, 2012 tmccoy
https://s3.amazonaws.com/lvs-yourlawyer/123-yourlawyer-falkowitz-the-use-of-chantix-and-depression.mp4
More than 13 million people have been prescribed prescription drugs such as Chantix to help stop smoking. Business is so good the manufacturer of the drug, Pfizer, reported more than $755 billion in annual sales.
With smokers trying everything from nicotine gum, electronic cigarettes, and even therapy, it’s not shocking that a drug like this has become popular. So it’s a great drug to help you quit smoking, what can the problem be? Well, what’s being reported are a large number of adverse side effects that the drug is causing, from changes in behavior and depressed mood to outright suicidal thoughts and actual suicide behavior in some patients.
The drug is comprised of a compound called varenicline which does not contain nicotine. After it was introduced to the market in 2006, sales have skyrocketed and it’s one of the best sellers on the market. But it’s also being linked to causing serious harm in patients. Patients experiencing these serious side effects are sending an alarming message to the FDA, who has issued an advisory regarding the drug’s safety to the public. The agency has even gone as far as forcing the company to conduct a clinic trial focusing on the safety of the drug, but that information will not be available until 2017. Until then, millions more can be at risk. Watch this video now to learn more.
To learn more about prescription drugs, I encourage you to watch the video above and to explore our educational website. If you have legal questions, I want you to call me at (800) 800-9797. I welcome your call.
